Skip to main content
. 2020 Sep 10;15(22):2121–2135. doi: 10.1002/cmdc.202000391

Figure 7.

Figure 7

(a) Cell viability of cervical cancer SiHa and ME180 cells upon treatments with cisplatin and olaparib alone or in combination, as determined by MTT assay. (b) Clonogenic survival of cervical cancer cells upon treatments with cisplatin, olaparib or both. (c) Quantification of the percentage of cells showing γH2A.X+53BP1+cells as DNA damage marker upon treatments with the respective mentioned groups. (d) Quantification of relative co‐localisation of XRCC4/KU80/XRCC4 foci and γH2A.X foci in the respective mentioned groups. Figure adapted from reference 115 under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/). Published by Springer Nature Limited. © The Author 2017.